Becette V - Search Results

1

Immunomarker studies of fine-needle cytopuncture cell blocks for tumor response prediction after preoperative chemotherapy and prognosis in operable nonmetastatic primary breast carcinoma.

Becette V, Lerebours F, Spyratos F, Menet E, Tubiana-Hulin M, Briffod M. Becette V, et al. Breast J. 2011 Mar-Apr;17(2):121-8. doi: 10.1111/j.1524-4741.2010.01040.x. Epub 2011 Feb 10. Breast J. 2011. PMID: 21306468

2

Influence of the extraction procedure on plasminogen activator inhibitor-2 (PAI-2) and urokinase receptor (uPAR) assays in breast cancer tissues.

Bouchet-Bernet C, Spyratos F, Andrieu C, Deytieux S, Bécette V, Oglobine J. Bouchet-Bernet C, et al. Among authors: becette v. Breast Cancer Res Treat. 1996;41(2):141-6. doi: 10.1007/BF01807159. Breast Cancer Res Treat. 1996. PMID: 8944332

3

Prognostic value of urokinase plasminogen activator in primary breast carcinoma: comparison of two immunoassay methods.

Bouchet C, Spyratos F, Hacène K, Durcos L, Bécette V, Oglobine J. Bouchet C, et al. Among authors: becette v. Br J Cancer. 1998 May;77(9):1495-501. doi: 10.1038/bjc.1998.246. Br J Cancer. 1998. PMID: 9652768 Free PMC article.

4

Dissemination risk index based on plasminogen activator system components in primary breast cancer.

Bouchet C, Hacène K, Martin PM, Becette V, Tubiana-Hulin M, Lasry S, Oglobine J, Spyratos F. Bouchet C, et al. Among authors: becette v. J Clin Oncol. 1999 Oct;17(10):3048-57. doi: 10.1200/JCO.1999.17.10.3048. J Clin Oncol. 1999. PMID: 10506599

5

[Breast cancer: prognostic value of a dissemination index based on 4 components of the urokinase-type plasminogen activator system].

Bouchet C, Hacène K, Martin PM, Becette V, Tubiana-Hulin M, Lasry S, Oglobine J, Spyratos F. Bouchet C, et al. Among authors: becette v. Pathol Biol (Paris). 2000 Nov;48(9):825-31. Pathol Biol (Paris). 2000. PMID: 11141918 French.

6

[Microcystic mammary tumor].

Driss Fourati M, Becette V, Briffod M, Rimareix F, Sabourin JC. Driss Fourati M, et al. Among authors: becette v. Ann Pathol. 2002 Jun;22(3):231-2. Ann Pathol. 2002. PMID: 12410109 French. No abstract available.

7

Prognostic value of uPA, PAI-1 and PAI-2 mRNA expression in primary breast cancer.

Spyratos F, Bouchet C, Tozlu S, Labroquere M, Vignaud S, Becette V, Lidereau R, Bieche I. Spyratos F, et al. Among authors: becette v. Anticancer Res. 2002 Sep-Oct;22(5):2997-3003. Anticancer Res. 2002. PMID: 12530032

8

Limited prognostic value of c-erbB-2 compared to uPA and PAI-1 in primary breast carcinoma.

Bouchet C, Ferrero-Poüs M, Hacène K, Becette V, Spyratos F. Bouchet C, et al. Among authors: becette v. Int J Biol Markers. 2003 Jul-Sep;18(3):207-17. doi: 10.1177/172460080301800309. Int J Biol Markers. 2003. PMID: 14535592 Free article.

9

[Biopsy of breast microcalcifications using an 11-Gauge vacuum-assisted device: roles and challenges for the pathologist].

Becette V, Chérel P, Menet E, Yacoub S, Brain E, Hagay C, Guinebretière JM. Becette V, et al. Ann Pathol. 2003 Dec;23(6):496-507. Ann Pathol. 2003. PMID: 15094588 Review. French.

10

Gene transcript assay by real-time RT-PCR in epithelial breast cancer cells selected by laser microdissection.

Becette V, Vignaud S, Régnier C, Labroquére M, Fourme E, Menet E, Bièche I, Spyratos F. Becette V, et al. Int J Biol Markers. 2004 Apr-Jun;19(2):100-8. doi: 10.1177/172460080401900203. Int J Biol Markers. 2004. PMID: 15255541 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters